Groundbreaking achievement by Safencap, an up and coming industry leader

OTTAWA, ON, January 30, 2024 /24-7PressRelease/ — InventionShare Inc., a platform technology monetization company, is thrilled to announce a groundbreaking achievement by its client Safencap. Safencap, an industry leader with an impressive international patent portfolio and a highly acclaimed team, has developed a revolutionary solution in the form of NON MICROPLASTIC microcapsules. This innovation sets a new industry standard for sustainability and safety.

Microcapsules have played a pivotal role in various industries, including cosmetics, fragrances and air fresheners, food and beverages, agriculture and crop management, through to nutraceuticals and dietary supplements. However, the environmental concerns associated with the widespread use of microplastics have prompted the Safencap team to develop an innovative alternative. Safencap’s microcapsules are not only non-microplastic but also non-toxic, “body safe,” and biodegradable.

Key Achievements:
• NON MICROPLASTIC Innovation: Safencap has successfully created microcapsules that are entirely free of microplastics. ALL current “solid” microcapsules (excluding “soft” and melting microcapsules such as alginate) are microplastics (polyurea, melamine, etc.). Unlike conventional microcapsules that rely on materials, Safencap employs sustainable Poly(beta-amino ester)s (PBAE) alternatives that do not contribute to the global microplastic pollution crisis and are well known and trusted in the medical and life sciences markets.
• Non Toxic and “Body Safe”: Prioritizing safety and sustainability, Safencap’s microcapsules undergo rigorous testing, ensuring they meet the highest standards for human health and environmental friendliness.
• Biodegradable Focus: Safencap is committed to sustainability and is already exceeding anticipated European standards, even before regulatory requirements come into effect.
InventionShare believes that this groundbreaking innovation will transform industries reliant on microcapsules through licensing, joint ventures, and exclusive field-of-use rights, providing eco-friendly and safe alternatives to customers. The company remains steadfast in its commitment to making a positive impact on the planet and future generations.

Greg Waite, CEO of InventionShare, expresses his enthusiasm, stating, “We are excited to introduce Safencap’s NON MICROPLASTIC microcapsules, a testament to the Safencap team’s unwavering dedication to sustainability and safety. Our pursuit of innovation perfectly aligns with our vision of creating a healthier, more environmentally friendly future.”

Yves Ortais, the founder and visionary behind Safencap adds, “We are bringing enormous ESG and regulatory advantage to Tier 1 suppliers and OEM producers. Our strong IP position coupled by our team’s implementation skills can provide more than 5 years of time to market advantage”.

InventionShare focuses on platform technologies with broad applications across various vertical and horizontal markets. Their dedication to people and the planet drives them to accelerate adoption through partnerships with large global companies, either as licensed partners or through early acquisitions.

Safencap is a branded platform that represents a team of industry experts in advanced microencapsulation technology, boasting an international patent portfolio, trade secrets, and unparalleled know-how. InventionShare collaborates with industry leaders to promote the adoption of Safencap technology and brand, benefiting both people and the planet. The Safencap team remains dedicated to making a positive impact on the world through eco-friendly solutions. For more information and to view a video visit

For the original version of this press release, please visit here